ipamorelin clinical trial lean body mass Weight Loss CJC-1295/Ipamorelin Benefits, Side Effects, and

Administered via subcutaneous injection at typical doses of 200-300 mcg daily, ipamorelin has a short half-life of approximately two hours but produces both immediate and sustained growth hormone pulses without elevating cortisol levels

Key Regulatory Points: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical" not intended for human use Compounding pharmacy restrictions were significantly tightened in late 2024 Sports / WADA CJC-1295 is explicitly prohibited by the World Anti-Doping Agency (WADA)

MK-677 and Ipamorelin have been researched for their role in recovery and muscle growth with each compound offering different advantages

CJC-1295 extends the half-life of each growth hormone pulse by binding to GHRH receptors and resisting enzymatic breakdown